Company Filing History:
Years Active: 2002-2003
Title: Innovations by David C Hopp
Introduction
David C Hopp is an accomplished inventor based in Mill Creek, WA (US). He has made significant contributions to the field of hypoglycemic and hypotriglyceridemic agents through his innovative research and patents. With a total of three patents to his name, Hopp's work focuses on the use of stilbenoid compounds for health benefits.
Latest Patents
Hopp's latest patents include "Compositions containing hypoglycemically active stilbenoids" and "Methods of using compositions containing hypotriglyceridemically active stilbenoids." The first patent describes the use of isolated or purified stilbenoid compounds, including longistyline A-2-carboxylic acid, as hypoglycemic agents to lower serum glucose levels. It also explores the combination of these compounds with other hypoglycemic agents. The second patent outlines the use of the same stilbenoid compounds as dietary supplements for mammals suffering from elevated triglyceride levels, again emphasizing their potential in combination with other hypotriglyceridemic agents.
Career Highlights
David C Hopp is currently associated with Insmed Incorporated, where he continues to advance his research in the field of medicinal compounds. His work has garnered attention for its potential impact on health and wellness, particularly in managing blood sugar and triglyceride levels.
Collaborations
Hopp collaborates with Wayne D Inman, contributing to the innovative research environment at Insmed Incorporated. Their combined expertise enhances the development of new therapeutic solutions.
Conclusion
David C Hopp's contributions to the field of hypoglycemic and hypotriglyceridemic agents through his patents reflect his dedication to improving health outcomes. His innovative work continues to pave the way for advancements in medicinal compounds.